08Apr/14

Gilead aims to license hepatitis C drug to 3-4 Indian firms – Reuters India


The Pharma Letter

Gilead aims to license hepatitis C drug to 3-4 Indian firms
Reuters India
We’re nailing down the geographical scope, and we should have these licences in place and ready to go in short order,” Samuel said on a visit to London for an international liver conference. He said Gilead was looking to strike deals with firms that
WHO Calls For ‘Concerted Effort’ To Bring Down Hepatitis C Drug CostsHuffington Post
WHO joins clamor to make new Hepatitis C pills affordableGMA News

all 82 news articles »

08Apr/14

Managing chronic kidney disease in primary care: a practice guide for practice … – Nursing in Practice

Managing chronic kidney disease in primary care: a practice guide for practice
Nursing in Practice
Chronic kidney disease is defined as irreversible kidney damage leading to structural abnormality with proteinuria and/or haematuria, and/or glomerular filtration rate (GFR) <60ml/min/1.73m&sup2;.1 Glomerular filtration rate describes the flow rate of

08Apr/14

Ears, noses grown from stem cells in lab dishes – CBS News


The Province

Ears, noses grown from stem cells in lab dishes
CBS News
Later this year, a trial is scheduled to start in India and London to test lab-made ears for people born without them. “Ears are harder to make than noses because you have to get all the … “Scientists have to get things like noses and ears right
Noses, made in Britain: UK touts lab-grown organsWashington Post

all 88 news articles »